Product NDC: | 0003-3622 |
Proprietary Name: | REYATAZ |
Non Proprietary Name: | ATAZANAVIR SULFATE |
Active Ingredient(s): | 300 mg/1 & nbsp; ATAZANAVIR SULFATE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, GELATIN COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0003-3622 |
Labeler Name: | E.R. Squibb & Sons, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021567 |
Marketing Category: | NDA |
Start Marketing Date: | 20030624 |
Package NDC: | 0003-3622-12 |
Package Description: | 30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3622-12) |
NDC Code | 0003-3622-12 |
Proprietary Name | REYATAZ |
Package Description | 30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3622-12) |
Product NDC | 0003-3622 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ATAZANAVIR SULFATE |
Dosage Form Name | CAPSULE, GELATIN COATED |
Route Name | ORAL |
Start Marketing Date | 20030624 |
Marketing Category Name | NDA |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | ATAZANAVIR SULFATE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC] |